Financials

News Ideas Discussions Technicals Forecast Seasonals Options

Current ratio of MoonLake Immunotherapeutics

Annual data

2021

2022

2023

2024

‪0.00‬

‪15.00‬

‪30.00‬

‪45.00‬

‪60.00‬

Period

Value

Change

Change %

2024

‪21.11‬

‪−30.48‬

‪−59.08‬%

2023

‪51.59‬

+‪41.61‬

+‪416.90‬%

2022

‪9.98‬

+‪9.52‬

+‪‪2.08 K‬‬%

2021

‪0.46‬

‪−12.48‬

‪−96.47‬%

Quarterly data

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪0.00‬

‪20.00‬

‪40.00‬

‪60.00‬

‪80.00‬

Period

Value

Change

Change %

Q4 '24

‪21.11‬

‪−4.40‬

‪−17.24‬%

Q3 '24

‪25.51‬

‪−18.20‬

‪−41.64‬%

Q2 '24

‪43.71‬

‪−18.41‬

‪−29.64‬%

Q1 '24

‪62.13‬

+‪10.53‬

+‪20.42‬%

Q4 '23

‪51.59‬

+‪3.09‬

+‪6.36‬%

Q3 '23

‪48.51‬

‪−22.47‬

‪−31.65‬%

Q2 '23

‪70.97‬

+‪61.84‬

+‪676.86‬%

Q1 '23

‪9.14‬

‪−0.85‬

‪−8.47‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20